Birmingham Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
6,300
-200
-3% -$41.6K 0.57% 40
2026
Q1
$1.37M Hold
6,500
0.58% 40
2025
Q4
$1.34M Hold
6,500
0.59% 40
2025
Q3
$1.02M Hold
6,500
0.47% 45
2025
Q2
$1.09M Hold
6,500
0.48% 48
2025
Q1
$896K Hold
6,500
0.34% 60
2024
Q4
$769K Hold
6,500
0.28% 66
2024
Q3
$718K Sell
6,500
-1,200
-16% -$125K 0.26% 61
2024
Q2
$757K Hold
7,700
0.3% 60
2024
Q1
$862K Sell
7,700
-350
-4% -$37.8K 0.32% 61
2023
Q4
$811K Hold
8,050
0.32% 63
2023
Q3
$699K Buy
8,050
+350
+5% +$31.6K 0.29% 65
2023
Q2
$728K Sell
7,700
-350
-4% -$29.6K 0.3% 65
2023
Q1
$608K Hold
8,050
0.24% 75
2022
Q4
$619K Hold
8,050
0.23% 73
2022
Q3
$537K Hold
8,050
0.24% 76
2022
Q2
$421K Hold
8,050
0.17% 85
2022
Q1
$456K Sell
8,050
-6,600
-45% -$353K 0.16% 88
2021
Q4
$754K Sell
14,650
-450
-3% -$22.1K 0.27% 74
2021
Q3
$747K Hold
15,100
0.29% 69
2021
Q2
$862K Sell
15,100
-449
-3% -$26.2K 0.32% 63
2021
Q1
$945K Sell
15,549
-626
-4% -$34.6K 0.35% 59
2020
Q4
$866K Sell
16,175
-350
-2% -$18.2K 0.36% 58
2020
Q3
$776K Buy
16,525
+350
+2% +$18K 0.35% 60
2020
Q2
$844K Sell
16,175
-150
-0.9% -$7.73K 0.41% 59
2020
Q1
$783K Buy
16,325
+900
+6% +$46.7K 0.43% 57
2019
Q4
$780K Hold
15,425
0.35% 62
2019
Q3
$728K Sell
15,425
-2,050
-12% -$93.6K 0.34% 64
2019
Q2
$823K Sell
17,475
-1,080
-6% -$49.8K 0.37% 61
2019
Q1
$893K Sell
18,555
-600
-3% -$30.1K 0.4% 56
2018
Q4
$854K Hold
19,155
0.42% 55
2018
Q3
$1.03M Sell
19,155
-200
-1% -$10.2K 0.43% 54
2018
Q2
$945K Sell
19,355
-1,550
-7% -$87.9K 0.41% 56
2018
Q1
$1.31M Hold
20,905
0.54% 48
2017
Q4
$1.28M Buy
20,905
+202
+1% +$12.5K 0.49% 50
2017
Q3
$1.39M Buy
20,703
+43
+0.2% +$3.04K 0.55% 50
2017
Q2
$1.61M Buy
20,660
+2
+0% +$151 0.65% 49
2017
Q1
$1.69M Buy
20,658
+2
+0% +$157 0.68% 46
2016
Q4
$1.49M Buy
20,656
+44
+0.2% +$3.18K 0.63% 47
2016
Q3
$1.61M Sell
20,612
-600
-3% -$48.5K 0.71% 42
2016
Q2
$1.66M Buy
21,212
+1
+0% +$80 0.73% 42
2016
Q1
$1.74M Buy
21,211
+2
+0% +$163 0.71% 45
2015
Q4
$1.89M Sell
21,209
-349
-2% -$29.6K 0.77% 45
2015
Q3
$1.66M Sell
21,558
-798
-4% -$66.7K 0.72% 47
2015
Q2
$1.87M Buy
22,356
+1
+0% +$88 0.73% 49
2015
Q1
$2.02M Buy
22,355
+1
+0% +$86 0.77% 44
2014
Q4
$1.8M Sell
22,354
-425
-2% -$33.6K 0.7% 48
2014
Q3
$1.71M Sell
22,779
-20
-0.1% -$1.46K 0.65% 51
2014
Q2
$1.56M Sell
22,799
-400
-2% -$27.2K 0.57% 54
2014
Q1
$1.62M Hold
23,199
0.61% 51
2013
Q4
$1.55M Sell
23,199
-3,575
-13% -$218K 0.58% 55
2013
Q3
$1.4M Hold
26,774
0.55% 57
2013
Q2
$1.26M Buy
+26,774
New +$1.22M 0.53% 59

Other funds holding CAH

Birmingham Capital Management's CAH Position: Q2 2026 in Review

Birmingham Capital Management reduced its Cardinal Health (CAH) stake by 3.1% in Q2 2026, selling an estimated $41.6K and leaving 6,300 shares worth $1.5M. The position accounts for 0.57% of the portfolio, ranked #40.

Birmingham Capital Management first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.02M in Q1 2015. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Birmingham Capital Management held 6,300 shares of Cardinal Health worth $1.5M as of Q2 2026.
  • Birmingham Capital Management sold 200 Cardinal Health shares in Q2 2026, an estimated $41.6K.
  • Cardinal Health made up 0.57% of Birmingham Capital Management's portfolio in Q2 2026, its #40 holding.
  • Birmingham Capital Management first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Birmingham Capital Management's Cardinal Health position peaked at $2.02M in Q1 2015.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.